| Name: | Chlordiazepoxide EP impurity B |
| Catalogue No. | VL3650001 |
| CAS No. | 5958-24-7 |
| Molecular Formula | C₁₅H₁₀Cl₂N₂O |
| Molecular Weight | 305.16 |
| Status | In-stock |
| IUPAC Name | 2-(Chloromethyl)-6-chloro-4-phenylquinazoline 3-Oxide |
| Appearance | In-stock |
| Description | Chlordiazepoxide EP impurity B (CAS No: 5958-24-7) or 2-(Chloromethyl)-6-chloro-4-phenylquinazoline 3-Oxide is an impurity during the synthesis of Chlordiazepoxide. They find their principal use as antianxiety agents. Chlordiazepoxide has sedative, appetite-increasing, and low analgesic actions. It attaches to benzodiazepine receptors at the GABA-A ligand-gated chloride channel complex and increases GABA's inhibitory effects. |
| References | Childress, Scott J., and M. I. Gluckman. “1,4-Benzodiazepines.” Journal of Pharmaceutical Sciences, vol. 53, no. 6, June 1964, pp. 577–90, https://doi.org/10.1002/jps.2600530602. Ahwazi HH, Abdijadid S. Chlordiazepoxide. In: StatPearls. StatPearls Publishing, Treasure Island (FL); 2020. PMID: 31613439. |
